Tempus AI (NASDAQ:TEM) Research Coverage Started at Bank of America

Bank of America began coverage on shares of Tempus AI (NASDAQ:TEM) in a research report sent to investors on Tuesday, Marketbeat.com reports. The firm issued a buy rating and a $41.00 price target on the stock.

A number of other research analysts also recently issued reports on TEM. Needham & Company LLC started coverage on shares of Tempus AI in a research note on Tuesday. They issued a buy rating and a $47.00 price target for the company. Stifel Nicolaus started coverage on shares of Tempus AI in a research report on Tuesday. They set a buy rating and a $45.00 price objective for the company. William Blair initiated coverage on Tempus AI in a report on Tuesday. They issued an outperform rating on the stock. JPMorgan Chase & Co. began coverage on Tempus AI in a report on Tuesday. They set an overweight rating and a $42.00 price target for the company. Finally, Longbow Research started coverage on Tempus AI in a report on Tuesday. They issued a buy rating and a $48.00 price objective on the stock. Nine research analysts have rated the stock with a buy rating, According to MarketBeat.com, Tempus AI presently has a consensus rating of Buy and an average target price of $45.63.

Tempus AI Stock Performance

Shares of TEM opened at $37.50 on Tuesday. Tempus AI has a fifty-two week low of $22.89 and a fifty-two week high of $43.88.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.